Insider Trading April 15, 2026 04:22 PM

Exzeo CEO Adds to Stake with $32,301 Purchase Amid Stock Weakness

Paresh Patel buys 2,090 shares as Exzeo reports Q4 and full-year 2025 results in line with expectations

By Derek Hwang XZO
Exzeo CEO Adds to Stake with $32,301 Purchase Amid Stock Weakness
XZO

Exzeo Group Chief Executive Paresh Patel acquired 2,090 shares of the company’s common stock on April 14, 2026, in four transactions totaling $32,301 at prices between $16.14 and $16.19. The purchase comes while the shares have fallen 33% year-to-date and trade below their 52-week high. Patel now directly holds 1,612,013 shares and retains options on 5,000,000 additional shares exercisable at $23. Exzeo’s fourth-quarter and full-year 2025 results matched analyst forecasts, with diluted EPS of $0.25 and quarterly revenue of $53.32 million.

Key Points

  • Paresh Patel bought 2,090 Exzeo shares on April 14, 2026 for $32,301 in total.
  • Patel directly owns 1,612,013 shares and has options on 5,000,000 shares exercisable at $23, granted Oct. 1, 2021 vesting in installments.
  • Exzeo’s Q4 and full-year 2025 results matched expectations with diluted EPS of $0.25 and quarterly revenue of $53.32 million; shares have fallen 33% YTD and trade at $16.79 (52-week high $24.60).

Insider buying

Exzeo Group, Inc. reported that Chief Executive Officer Paresh Patel purchased shares of the company’s common stock on April 14, 2026. In four separate transactions executed that day, Patel acquired a combined 2,090 shares at prices ranging from $16.14 to $16.19, amounting to $32,301 in total.

Position after purchases

Following these transactions, Patel’s direct ownership in Exzeo stands at 1,612,013 shares. In addition to his direct holdings, Patel retains options to buy 5,000,000 shares of Exzeo Group common stock at an exercise price of $23 per share. Those options were granted on October 1, 2021 and vest in installments.

Share performance and analyst targets

The insider purchase occurs against a backdrop of notable share price weakness year-to-date. Exzeo shares have declined 33% so far this year and were trading at $16.79, which is below the company’s 52-week high of $24.60. Analysts that cover the company have set price targets in the range of $25 to $27.

Recent financial results

Separately, Exzeo Group Inc. released its fourth-quarter and full-year 2025 financial results, which the company said aligned with analyst expectations. For the quarter, Exzeo reported diluted earnings per share of $0.25 and quarterly revenue of $53.32 million. The company described these results as reflecting robust growth and noted that the earnings release prompted a positive response from investors.

Additional context from the company update

The earnings release did not include any announced mergers or acquisitions. The report also noted that analyst firms have not recently upgraded or downgraded the stock. Taken together, these items describe the company’s current financial standing as consistent with external forecasts.


Clear summary

Exzeo’s CEO bought 2,090 shares on April 14, 2026 for $32,301 as the stock trades well below its 52-week peak; the company’s latest quarterly and full-year 2025 results matched analysts’ forecasts, reporting $0.25 diluted EPS and $53.32 million in quarterly revenue.

Key points

  • Paresh Patel purchased 2,090 shares in four transactions at $16.14 to $16.19 on April 14, 2026, totaling $32,301.
  • Patel now directly owns 1,612,013 shares and holds options on 5,000,000 more shares exercisable at $23 that were granted October 1, 2021 and vest in installments.
  • Exzeo reported Q4 and full-year 2025 results in line with expectations: diluted EPS of $0.25 and quarterly revenue of $53.32 million; shares have fallen 33% year-to-date and trade at $16.79 versus a 52-week high of $24.60.

Risks and uncertainties

  • Share price volatility - The stock has declined 33% year-to-date and currently trades below its 52-week high, indicating recent market weakness that could affect investor returns.
  • Option strike gap - Patel’s options are exercisable at $23 per share, which is above the current trading price of $16.79; this gap may influence the timing and economics of any future option exercises.
  • Analyst coverage stability - The article notes that analyst firms have not recently issued upgrades or downgrades, leaving the stock without recent directional analyst actions to guide investors.

Risks

  • Share price has declined 33% year-to-date, reflecting recent market weakness that may persist and affect investor returns.
  • Executive stock options have a $23 exercise price, which is higher than the current trading price of $16.79, creating potential timing and valuation uncertainty for option exercises.
  • Analyst firms have not recently upgraded or downgraded the stock, leaving limited new analyst-driven guidance for investors.

More from Insider Trading

JPMorgan Co-CEO Douglas Petno Sells $1.7 Million in Stock Apr 15, 2026 JPMorgan Executive Disposes $1.97 Million in Stock as Bank Nears $38 Billion Loan Close for Oracle Apr 15, 2026 JPMorgan Asset & Wealth CEO Sells $3.78 Million in Stock Apr 15, 2026 JPMorgan CIO Disposes $970,659 in Stock; Bank Involved in $38B Oracle Loan Package Apr 15, 2026 Strategy Inc Director Patten Disposes $444,193 in Class A Shares, Simultaneously Exercises Options Apr 15, 2026